Profund Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.51M	Buy	158,462 +16,477	+12%	+$128K	0.06%	249
2025 Q4	$1.11M	Buy	141,985 +61,966	+77%	+$448K	0.03%	328
2025 Q3	$607K	Buy	80,019 +16,308	+26%	+$136K	0.02%	450
2025 Q2	$571K	Buy	63,711 +9,730	+18%	+$90.6K	0.02%	431
2025 Q1	$405K	Buy	53,981 +6,231	+13%	+$50.3K	0.02%	547
2024 Q4	$359K	Sell	47,750 -26,753	-36%	-$203K	0.01%	678
2024 Q3	$566K	Sell	74,503 -12,312	-14%	-$93.6K	0.02%	487
2024 Q2	$537K	Sell	86,815 -155,057	-64%	-$856K	0.02%	478
2024 Q1	$1.23M	Buy	241,872 +86,483	+56%	+$486K	0.05%	305
2023 Q4	$931K	Buy	155,389 +18,737	+14%	+$109K	0.04%	340
2023 Q3	$967K	Sell	136,652 -40,240	-23%	-$289K	0.05%	293
2023 Q2	$1.25M	Buy	176,892 +24,138	+16%	+$194K	0.07%	268
2023 Q1	$1.27M	Buy	+152,754	New	+$1.47M	0.08%	236